MAIA Biotechnology, Inc. (AMEX:MAIA) filed a Form 8-K with the Securities and Exchange Commission on January 20, 2026, disclosing a material event.
MAIA Biotechnology, Inc.'s stock currently trades at $2.20 with a market capitalization of $60,547,822. The Healthcare company's stock moved following the disclosure.